Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Patients With Schizophrenia

Background: The etiology of schizophrenia remains largely unknown but alterations in the immune system may be involved. In addition to the psychiatric symptoms, schizophrenia is also associated with up to 20 years reduction in life span. Soluble urokinase-type plasminogen activator receptor (suPAR)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Schizophr Bull
Autors principals: Nielsen, Jimmi, Røge, Rasmus, Pristed, Sofie Gry, Viuff, Anne Grethe, Ullum, Henrik, Thørner, Lise Wegner, Werge, Thomas, Vang, Torkel
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Regular Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4393680/
https://ncbi.nlm.nih.gov/pubmed/25154621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbu118
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars